[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ali et al., 2014 - Google Patents

Dye-doped fluorescent nanoparticles in molecular imaging: a review of recent advances and future opportunities

Ali et al., 2014

View HTML
Document ID
7571407864601096570
Author
Ali Y
Zohre R
Mostafa J
Samaneh R
Publication year
Publication venue
Material Science Research India

External Links

Snippet

Molecular imaging (MI) is an in vivo assessment of characterization and quantitatively measurement of biological processes at the molecular level. Determination of pathologies of malfunctioned tissues without invasive biopsies or surgical procedures, early detection …
Continue reading at www.materialsciencejournal.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANO-TECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANO-STRUCTURES; MEASUREMENT OR ANALYSIS OF NANO-STRUCTURES; MANUFACTURE OR TREATMENT OF NANO-STRUCTURES
    • B82Y30/00—Nano-technology for materials or surface science, e.g. nano-composites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle

Similar Documents

Publication Publication Date Title
Wang et al. MoS2-based nanocomposites for cancer diagnosis and therapy
Abdellatif et al. Biomedical applications of quantum dots: overview, challenges, and clinical potential
Zhang et al. Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications
Santra et al. Luminescent nanoparticle probes for bioimaging
Giner-Casares et al. Inorganic nanoparticles for biomedicine: where materials scientists meet medical research
Yao et al. Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy
Wang et al. Bioconjugated silica nanoparticles: development and applications
Rizvi et al. Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio-molecular and cellular imaging
Kogan et al. Peptides and metallic nanoparticles for biomedical applications
Azzazy et al. In vitro diagnostic prospects of nanoparticles
Wang et al. Engineering nanomaterial surfaces for biomedical applications
Medintz et al. Potential clinical applications of quantum dots
Zhang et al. Dye-doped fluorescent silica nanoparticles for live cell and in vivo bioimaging
Liu et al. Synthesis of GdAlO3: Mn4+, Ge4+@ Au core–shell nanoprobes with plasmon-enhanced near-infrared persistent luminescence for in vivo trimodality bioimaging
Chan Bionanotechnology progress and advances
Guo et al. Molecularly imprinted upconversion nanoparticles for highly selective and sensitive sensing of Cytochrome c
Chen et al. Turn-on detection of a cancer marker based on near-infrared luminescence energy transfer from NaYF4: Yb, Tm/NaGdF4 core–shell upconverting nanoparticles to gold nanorods
Ali et al. Dye-doped fluorescent nanoparticles in molecular imaging: a review of recent advances and future opportunities
Hofmann-Amtenbrink et al. Nanotechnology in medicine: European research and its implications
Probst et al. Luminescent nanoparticles and their use for in vitro and in vivo diagnostics
Wan et al. Biological nanoscale fluorescent probes: From structure and performance to bioimaging
Ullah Khan et al. Ultrasensitive detection of exosome using biofunctionalized gold nanorods on a silver-island film
Huang et al. Fluorescent-magnetic multifunctional nanoparticles for imaging and drug delivery
Shrestha et al. Nanotechnology for Personalized Medicine
CN102520188A (en) Intracellular protein detection method by flow cytometry